MyFinsight

HomeAboutContact
Curious boy with magnifying glass
A worm made of letters APL
A worm made of letters BOA

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2024 MyFinsight. All rights reserved.

Cryoport, Inc. (CYRX)

For the quarter ending 2025-06-30, CYRX made $45,454K in revenue. $103,180K in net income. Net profit margin of 227.00%.

Overview

Revenue
$45,454K
Net Income
$103,180K
Net Profit Margin
227.00%
EPS
$2.05
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • Biologistics Solutions
    • Biostorage Bioservices
Revenue Breakdown
    • Americas
    • Asia Pacific
    • EMEA

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
2025-06-30
2025-03-31
2024-09-30
2024-06-30
Total revenue45,454 41,040 56,664 57,597
Service12,449 - - -
Product11,628 - - -
Total cost of revenue24,077 22,399 31,279 32,407
Gross margin21,377 18,641 25,385 25,190
Asset impairment charges- - - 63,809
Selling, general and administrative26,908 24,191 37,654 35,963
Engineering and development4,118 3,934 4,157 4,646
Total operating costs and expenses31,026 28,125 41,811 104,418
Loss from operations-9,649 -9,484 -16,426 -79,228
Gain (loss) on extinguishment of debt- - 17,326 1,179
Other income (expense), net-2,939 -300 -1,616 -1,121
Investment income1,466 1,573 3,059 2,809
Interest expense618 583 889 1,245
Total other income (expense), net-2,091 690 17,880 1,622
Loss from continuing operations before provision for income taxes-11,740 -8,794 1,454 -77,606
Provision for income taxes274 234 649 383
Loss from continuing operations-12,014 -9,028 - -
Income (loss) from discontinued operations, net117,194 -2,953 - -
Net income (loss)105,180 -11,981 805 -77,989
Paid-in-kind dividend on series c convertible preferred stock2,000 2,000 2,000 2,000
Net income (loss) attributable to common stockholders103,180 -13,981 -1,195 -79,989
Earnings per share, basic2.05 -0.28 -0.02 -1.62
Earnings per share, diluted2.05 -0.28 -0.02 -1.62
Weighted average number of shares outstanding, basic50,257,112 49,947,012 49,417,757 49,345,644
Weighted average number of shares outstanding, diluted50,257,112 49,947,012 49,417,757 49,345,644
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement

DownloadDownload image
Income (loss) fromdiscontinued operations, net$117,194K Biologistics Solutions$19,874K Biostorage Bioservices$4,495K Net income (loss)$105,180K (234.87%↑ Y/Y)Loss from continuingoperations-$12,014K Product$21,085K Service$24,369K Net income (loss)attributable to common...$103,180K (228.99%↑ Y/Y)Paid-in-kind dividend onseries c convertible...$2,000K (0.00%↑ Y/Y)Loss from continuingoperations before...-$11,740K (84.87%↑ Y/Y)Provision for income taxes$274K (-28.46%↓ Y/Y)Total revenue$45,454K (-21.08%↓ Y/Y)Total other income(expense), net-$2,091K (-228.91%↓ Y/Y)Loss from operations-$9,649K (87.82%↑ Y/Y)Investment income$1,466K (-47.81%↓ Y/Y)Gross margin$21,377K (-15.14%↓ Y/Y)Total cost of revenue$24,077K (-25.70%↓ Y/Y)Interest expense$618K (-50.36%↓ Y/Y)Other income(expense), net-$2,939K (-162.18%↓ Y/Y)Total operating costsand expenses$31,026K (-70.29%↓ Y/Y)Product$11,628K Service$12,449K Engineering and development$4,118K (-11.36%↓ Y/Y)Selling, general andadministrative$26,908K (-25.18%↓ Y/Y)